Search

Author/Creator Lublin, Fred

1. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE). Issue 6 (24th May 2018)

Authors:
Kappos, Ludwig; Wolinsky, Jerry S; Giovannoni, Gavin; Arnold, Douglas L; Lublin, Fred; Wang, Qing; Model, Fabian; Wei, Wei; Garren, Hideki; Manfrini, Marianna; Belachew, Shibeshih; Hauser, Stephen
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis. (25th August 2020)

Authors:
Giovannoni, Gavin; Knappertz, Volker; Steinerman, Joshua R.; Tansy, Aaron P.; Li, Thomas; Krieger, Stephen; Uccelli, Antonio; Uitdehaag, Bernard M.J.; Montalban, Xavier; Hartung, Hans-Peter; Pia Sormani, Maria; Cree, Bruce A.C.; Lublin, Fred; Barkhof, Frederik
Journal:
Neurology
Issue:
Volume 95:Number 8(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials. (October 2020)

Authors:
Zhang, Yinan; Gonzalez Caldito, Natalia; Shirani, Afsaneh; Salter, Amber; Cutter, Gary; Culpepper, William; Wallin, Mitchell; Kosa, Peter; Bielekova, Bibiana; Lublin, Fred; Stϋve, Olaf
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 13(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials. (October 2020)

Authors:
Zhang, Yinan; Gonzalez Caldito, Natalia; Shirani, Afsaneh; Salter, Amber; Cutter, Gary; Culpepper, William; Wallin, Mitchell; Kosa, Peter; Bielekova, Bibiana; Lublin, Fred; Stuve, Olaf
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 13(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis. Issue 1 (23rd January 2023)

Authors:
Vasileiou, Eleni S.; Hu, Chen; Bernstein, Charles N.; Lublin, Fred; Wolinsky, Jerry S.; Cutter, Gary R.; Sotirchos, Elias S.; Kowalec, Kaarina; Salter, Amber; Saidha, Shiv; Mowry, Ellen M.; Calabresi, Peter A.; Marrie, Ruth Ann; Fitzgerald, Kathryn C.
Journal:
Neurology
Issue:
Volume 10:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Brain microstructural injury occurs in patients with RRMS despite 'no evidence of disease activity'. Issue 9 (16th March 2018)

Authors:
Harel, Asaff; Sperling, Dylan; Petracca, Maria; Ntranos, Achillefs; Katz-Sand, Ilana; Krieger, Stephen; Lublin, Fred; Wang, Zichen; Liu, Yangbo; Inglese, Matilde
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 9(2018)
Page Start:
977
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Cerebellar lobule atrophy and disability in progressive MS. Issue 12 (26th August 2017)

Authors:
Cocozza, Sirio; Petracca, Maria; Mormina, Enricomaria; Buyukturkoglu, Korhan; Podranski, Kornelius; Heinig, Monika M; Pontillo, Giuseppe; Russo, Camilla; Tedeschi, Enrico; Russo, Cinzia Valeria; Costabile, Teresa; Lanzillo, Roberta; Harel, Asaff; Klineova, Sylvia; Miller, Aaron; Brunetti, Arturo;...
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 88:Issue 12(2017)
Page Start:
1065
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: A retrospective analysis from the CombiRx trial. (17th November 2021)

Authors:
Petracca, Maria; Cutter, Gary; Cocozza, Sirio; Freeman, Leorah; Kangarlu, John; Margoni, Monica; Moro, Matteo; Krieger, Stephen; El Mendili, Mohamed Mounir; Droby, Amgad; Wolinsky, Jerry S.; Lublin, Fred; Inglese, Matilde
Journal:
European journal of neurology
Issue:
Volume 29:Number 2(2022)
Page Start:
515
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

Authors:
Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu...
Journal:
Lancet neurology
Issue:
Volume 21:Issue 7(2022)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗